Molecular and Treatment Characteristics of SMARCB1 or SMARCA4-Deficient Undifferentiated Tumor: Retrospective Case Series
Cancer Research and Treatment · 2024
DOI: 10.4143/crt.2023.1308 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Research and Treatment, 2024. Verfasst von Hyeon Gyu Kang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: DNA Helicases, SMARCB1 Protein, Transcription Factors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
SMARCB1 or SMARCA4-deficient sinonasal carcinoma or thoracic undifferentiated tumor has aggressive nature with a poor prognosis. Patients with this disease were diagnosed by immunohistochemistry or next-generation sequencing. Those who were able to receive a surgery tended to be cured, while the others treated with chemotherapy, radiation therapy, or immune checkpoint inhibitor were often insensitive to these therapies. However, one having CD274 (PD-L1) amplification showed the response to immune checkpoint inhibitor and a good prognosis. We believed that this report could provide promising information for determining the optimal treatment option.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Seoul National University College of Medicine, Seoul, Korea.
- Department of Pathology, Seoul National University Hospital, Seoul, Korea.
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
- Department of Otorhinolaryngology, Seoul National University Hospital, Seoul, Korea.
Zitieren
APA
Kang, H. G., Koh, J., Kim, T. M., Han, D. H., Won, T. B., Kim, D. W., Kim, D. Y., & Keam, B. (2024). Molecular and Treatment Characteristics of SMARCB1 or SMARCA4-Deficient Undifferentiated Tumor: Retrospective Case Series. Cancer Research and Treatment. https://doi.org/10.4143/crt.2023.1308
Vancouver
Kang HG, Koh J, Kim TM, Han DH, Won TB, Kim DW, et al. Molecular and Treatment Characteristics of SMARCB1 or SMARCA4-Deficient Undifferentiated Tumor: Retrospective Case Series. Cancer Research and Treatment. 2024. doi:10.4143/crt.2023.1308
BibTeX
@article{Kang2024,
author = {Kang, Hyeon Gyu and Koh, Jiwon and Kim, Tae Min and Han, Doo Hee and Won, Tae-Bin and Kim, Dong-Wan and Kim, Dong-Young and Keam, Bhumsuk},
title = {Molecular and Treatment Characteristics of SMARCB1 or SMARCA4-Deficient Undifferentiated Tumor: Retrospective Case Series},
journal = {Cancer Research and Treatment},
year = {2024},
doi = {10.4143/crt.2023.1308}
}
EUVIMED